CD28 and IL-6 receptor antagonists
Showing 1 - 25 of >10,000
IL-6 and Its Receptor Antagonists in Children's Severe Sepsis.
Withdrawn
- Critical Illness Sepsis, Severe
- (no location specified)
Jun 13, 2022
Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte
Active, not recruiting
- Adult Acute Myeloid Leukemia in Remission
- +12 more
- cyclophosphamide
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Non-Hodgkin Lymphoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in United States (NKTR-255 at 1.5 µg/kg, NKTR-255
Recruiting
- Non-Hodgkin Lymphoma
- Relapsed/Refractory Diffuse Large B-cell Lymphoma
- NKTR-255 at 1.5 µg/kg
- +3 more
-
La Jolla, California
- +26 more
Jan 10, 2023
Interleukin 6 Receptor Antagonists in Corona Virus Disease 19
Recruiting
- Corona Virus Infection
- ELISA
-
Assiut, EgyptAssiutU
Feb 2, 2023
IL-1ß and Its Receptor Antagonists in Treatment of Severe
Withdrawn
- Critical Illness
- Sepsis, Severe
- (no location specified)
Jun 13, 2022
Non Hodgkin's Lymphoma Trial in Beijing (TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T),
Not yet recruiting
- Non Hodgkin's Lymphoma
- TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
- +2 more
-
Beijing, China
- +2 more
Aug 23, 2023
COVID-19, Hospitalized COVID-19 Patients Trial in Zgharta, Tripoli (Lopinavir / Ritonavir, Remdesivir (RDV), Tocilizumab)
Recruiting
- COVID-19
- Hospitalized COVID-19 Patients
- Lopinavir / Ritonavir
- +3 more
-
Zgharta, North, Lebanon
- +1 more
Jun 28, 2023
Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Tocilizumab)
Recruiting
- Adamantinomatous Craniopharyngioma
- Recurrent Adamantinomatous Craniopharyngioma
-
Aurora, Colorado
- +17 more
Jan 8, 2023
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR
Not yet recruiting
- Pericarditis
- IL1RA Antibody Assay
- suPAR Testing
-
Homburg, Germany
- +8 more
Jun 22, 2023
Refractory B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Small Lymphocytic Lymphoma, Relapsed Adult ALL Trial in Houston
Recruiting
- Refractory B-Cell Non-Hodgkin Lymphoma
- +4 more
- CD19.CAR-aNKT cells
- +2 more
-
Houston, Texas
- +1 more
Aug 19, 2022
Renal Transplant Rejection, Induction Therapy Trial (Rabbit Anti thymocyte globulin (rATG), Basiliximab)
Not yet recruiting
- Renal Transplant Rejection
- Induction Therapy
- Rabbit Anti thymocyte globulin (rATG)
- Basiliximab
- (no location specified)
Sep 22, 2022
Glioblastoma Trial in Gainesville (Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells)
Not yet recruiting
- Glioblastoma
- Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells
-
Gainesville, FloridaUniversity of Florida Health
Jul 29, 2022
Anti-IL-6 Receptor Monoclonal Antibodies on Treatment of
Recruiting
- Rheumatoid Arthritis
- +3 more
-
Barcelona, SpainHospital de la Santa Creu i Sant Pau
Apr 25, 2022
Interleukin-6 Inhibition, Physical Stress, Appetitive Behavior Trial in Copenhagen Ø (Tocilizumab Injectable Product, Saline
Completed
- Interleukin-6 Inhibition
- +2 more
- Tocilizumab Injectable Product
- Saline 0.9% 100 ml NaCl 0.9% will be infused over 1 hour
-
Copenhagen Ø, DenmarkCenter For Physical Activity (CFAS)
Aug 19, 2022
MDD Trial (Tocilizumab, Placebo, Whole-Body Hyperthermia)
Not yet recruiting
- Major Depressive Disorder
- Tocilizumab
- +2 more
- (no location specified)
Aug 23, 2022
CNS Lymphoma Trial in Duarte (procedure, biological, drug)
Recruiting
- Central Nervous System Lymphoma
- Aspiration
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Breast Cancer With or Without BRCA Mutation
Recruiting
- Breast Cancer
- Androgen receptor status and BRCA mutation
-
Varanasi, UP, IndiaBanaras Hindu University
Jun 2, 2022
Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL) Trial in Milwaukee (8/12-Day
Recruiting
- Non Hodgkin Lymphoma (NHL)
- +6 more
- 8/12-Day Production of Car-T Cells
- +2 more
-
Milwaukee, WisconsinMedical College of Wisconsin and Froedtert Hospital
Jul 1, 2022
Non-Hodgkin Lymphoma Trial in Columbus (Biospecimen Collection, Computed Tomography, Positron Emission Tomography)
Recruiting
- Non-Hodgkin Lymphoma
- Biospecimen Collection
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jan 13, 2023
Tumor Necrosis Factor-alpha Antagonists in Rheumatoid Arthritis.
Recruiting
- Rheumatoid Arthritis
- +2 more
- Infliximab: Adalimumab; Etanercept;
-
Sulaymaniyah, Kurdistan Region, IraqHiwa Khidhir Saaed
May 12, 2022
Mesothelioma, Mesotheliomas Pleural, Mesothelioma, Malignant Trial in Bethesda, Nashville (TC-510, Fludarabine,
Recruiting
- Mesothelioma
- +14 more
- TC-510
- +2 more
-
Nashville, TennesseeSarah Cannon Research Institute
Jul 14, 2022
Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis
Not yet recruiting
- Rheumatoid Arthritis
- (no location specified)
Oct 4, 2022